The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive characterization of interleukin-enhanced factor 2 (ILF2) in triple-negative breast cancer (TNBC).
 
Matias Bustos
No Relationships to Disclose
 
Sachin Kumar Deshmukh
Employment - Caris Life Sciences
 
Timothy Samec
Employment - Caris Life Sciences
Patents, Royalties, Other Intellectual Property - Tandem peptide for delivery of nucleic acid cargos - Clemson University
 
Sharon Wu
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Joanne Xiu
No Relationships to Disclose
 
Pooja Advani
Stock and Other Ownership Interests - Abbvie (I); Alpha2 Pharmaceuticals (I); NanoString Technologies (I); Sorrento Therapeutics (I)
Honoraria - Ascentage Pharma Group (I); AstraZeneca (I); AstraZeneca (Inst); Epic Sciences; Epic Sciences; GE Healthcare; Menarini Group; OncLive/MJH Life Sciences
Consulting or Advisory Role - Ascentage Pharma (I); AstraZeneca (I); AstraZeneca (Inst); BMS (I); Breathe BioMedical; Puma Biotechnology
Speakers' Bureau - AstraZeneca (Inst); GE hea; Menarini
Research Funding - Ascentage Pharma (I); AstraZeneca (Inst); Atossa Therapeutics (Inst); Ayala Pharmaceuticals (Inst); biovica (Inst); Bristol Myer Squibb (I); Caris Life Sciences (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Loxo/Lilly (Inst); Seagan (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - patent pending on PCT-US2020-067237 (cancer vaccine platform) (I)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus (I)
 
Priya Jayachandran
No Relationships to Disclose
 
Reshma Mahtani
Consulting or Advisory Role - Agendia; Amgen; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech/Roche; Gilead Sciences; Hologic/Biotheranostics; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Sermonix Pharmaceuticals; Stemline Therapeutics
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Seagen
 
Stephanie Graff
Stock and Other Ownership Interests - HCA Healthcare
Honoraria - Wolters Kluwer
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Menarini; Novartis; Pfizer
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Novartis (Inst)
Other Relationship - Dr. Susan Love Foundation for Breast Cancer Research
(OPTIONAL) Uncompensated Relationships - The Dempsey Center
 
Maryam Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Menarini; Novartis; Osmol Therapeutics; Pfizer
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic
 
Janie Grumley
No Relationships to Disclose
 
George Sledge
Employment - Caris Life Sciences
Leadership - Caris Life Sciences; Syndax
Stock and Other Ownership Interests - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Dave Hoon
No Relationships to Disclose